Bacterial evolution continues to challenge established control measures
A newly identified antibiotic resistance mechanism could make one of healthcare's most challenging pathogens even harder to control, according to researchers from Monash University. The study found that Clostridioides difficile can acquire a resistance gene that enables it to produce tougher spores capable of surviving hospital grade disinfectants and high temperature laundry processes.
Published in Nature Communications, the research provides new insight into the relationship between antimicrobial resistance and the environmental persistence of healthcare associated pathogens. The authors say it is the first study to identify a direct link between antibiotic resistance and bacterial spore formation.
The findings have important implications for infection prevention and control, particularly in hospitals and other healthcare settings where C. difficile remains a significant cause of healthcare associated diarrhoea and can be life threatening for vulnerable patients.
Unlike actively growing bacteria, C. difficile spores can remain dormant in the environment for extended periods. Researchers compare them to plant seeds, remaining inactive until conditions favour growth and transmission, such as when they reach the human gastrointestinal tract.
According to Professor Dena Lyras, Interim Dean of the Monash Sub Faculty of Biomedical and Psychological Sciences and Director of the Monash Biomedicine Discovery Institute, the study highlights another way bacteria are adapting in response to antimicrobial pressure.
"Antibiotics are helping bacteria evolve in ways we hadn't anticipated," Professor Lyras said. "Our new research shows just how sophisticated their evolution is, with the potential to have disastrous impacts on humans."
The researchers found that certain antibiotics would normally prevent C. difficile from forming spores. However, when the bacterium acquires the newly identified resistance gene, that mechanism is bypassed and spore formation can continue. The gene produces a protein that replaces a key spore building protein, allowing the bacterium to keep producing spores despite antibiotic exposure.
Importantly, the resulting spores appear to be more resilient than usual. Researchers reported that they were able to withstand hospital grade cleaning products and high temperature laundering processes that would typically be used to reduce environmental contamination.
Professor Lyras said the findings demonstrate that bacterial adaptation extends beyond resistance to antimicrobial treatment alone.
"They are not only better at building tolerance to drugs we develop, but making new versions of themselves that can survive better in particular environments, like surfaces where cleaning products are commonly applied," Professor Lyras said.
From a public health and infection control perspective, the study raises concerns about how antimicrobial resistance may influence disease transmission. Because spores are the primary mechanism through which C. difficile spreads between patients and persists in healthcare environments, any adaptation that improves spore survival has the potential to make outbreaks more difficult to prevent and contain.
First author Dr Yogitha Srikhanta, Post Doctoral Research Fellow at the Monash Biomedicine Discovery Institute, said understanding and targeting spores may be key to future control strategies.
"Spore survival matters because spores are the main way these pathogens spread between people and through hospitals, homes, and the environment," Dr Srikhanta said.
"A resistance gene that changes how spores are built could make infections harder to control and help resistant strains spread more easily," Dr Srikhanta said. "We are now investigating ways to deal with this new type of antibiotic resistance."
The findings also reinforce the importance of antimicrobial stewardship. Antibiotic exposure is a well recognised risk factor for C. difficile infection because it can disrupt normal gut microbiota and create conditions that allow the pathogen to establish and proliferate. Broader antibiotic use also contributes to selective pressures that favour resistant strains.
For clinicians, the study highlights the continued importance of infection prevention measures alongside prudent antibiotic prescribing. Hand hygiene, environmental cleaning, contact precautions and antimicrobial stewardship remain central components of efforts to reduce C. difficile transmission within healthcare settings.
The World Health Organization identifies antimicrobial resistance as one of the most significant global health threats, contributing to millions of deaths each year. The authors say their findings add another dimension to this challenge by demonstrating how resistance mechanisms may improve bacterial survival in the environment as well as resistance to treatment.
While further research is needed to determine the full clinical implications, the discovery provides new insight into how healthcare associated pathogens continue to evolve and highlights the need for ongoing investment in infection prevention, surveillance and antimicrobial stewardship programs.